Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-285792
Filing Date
2015-08-11
Accepted
2015-08-11 08:02:17
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d69346d10q.htm 10-Q 522676
2 EX-31.1 d69346dex311.htm EX-31.1 8206
3 EX-31.2 d69346dex312.htm EX-31.2 8196
4 EX-32.1 d69346dex321.htm EX-32.1 4207
  Complete submission text file 0001193125-15-285792.txt   3018328

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20150630.xml EX-101.INS 465598
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20150630.xsd EX-101.SCH 37943
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20150630_cal.xml EX-101.CAL 54563
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20150630_def.xml EX-101.DEF 114932
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20150630_lab.xml EX-101.LAB 320984
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20150630_pre.xml EX-101.PRE 217668
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 151042499
SIC: 2834 Pharmaceutical Preparations